AR044831A1 - Forma de administracion inyectable de la flupirtina - Google Patents
Forma de administracion inyectable de la flupirtinaInfo
- Publication number
- AR044831A1 AR044831A1 ARP040102141A ARP040102141A AR044831A1 AR 044831 A1 AR044831 A1 AR 044831A1 AR P040102141 A ARP040102141 A AR P040102141A AR P040102141 A ARP040102141 A AR P040102141A AR 044831 A1 AR044831 A1 AR 044831A1
- Authority
- AR
- Argentina
- Prior art keywords
- flupirtina
- administration form
- injectable administration
- lyophilisate
- prepare
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Un liofilizado que contiene flupirtina, al uso del liofilizado para preparar una composición farmacéutica destinada a ser administrada por vía parenteral, a un procedimiento para preparar una composición farmacéutica que contiene flupirtina, destinada a ser administrada por vía parenteral, a un procedimiento para preparar el liofilizado que contiene la flupirtina, así como a la composición farmacéutica que contiene flupirtina, preparada usando el liofilizado.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10327674A DE10327674A1 (de) | 2003-06-20 | 2003-06-20 | Injizierbare Darreichungsform von Flupirtin |
Publications (1)
Publication Number | Publication Date |
---|---|
AR044831A1 true AR044831A1 (es) | 2005-10-05 |
Family
ID=33495162
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040102141A AR044831A1 (es) | 2003-06-20 | 2004-06-18 | Forma de administracion inyectable de la flupirtina |
Country Status (18)
Country | Link |
---|---|
US (1) | US20060252804A1 (es) |
EP (2) | EP1987819B1 (es) |
JP (1) | JP4617303B2 (es) |
KR (1) | KR20060025182A (es) |
CN (1) | CN1838943A (es) |
AR (1) | AR044831A1 (es) |
AT (2) | ATE553085T1 (es) |
CA (1) | CA2528899A1 (es) |
DE (2) | DE10327674A1 (es) |
DK (1) | DK1987819T3 (es) |
EA (1) | EA008145B1 (es) |
ES (2) | ES2388088T3 (es) |
PL (2) | PL1987819T3 (es) |
PT (1) | PT1987819E (es) |
RS (1) | RS20050941A (es) |
TW (1) | TWI343261B (es) |
UA (1) | UA84155C2 (es) |
WO (1) | WO2004112754A1 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7592002B2 (en) * | 2005-10-31 | 2009-09-22 | Bioderm Research | Sugar esters for depilation (hair removal), demabrasion, and wrinkles reduction |
JP5283050B2 (ja) * | 2005-02-07 | 2013-09-04 | 国立大学法人京都大学 | 繊維強化複合材料 |
WO2008020584A1 (fr) * | 2006-08-14 | 2008-02-21 | Eisai R & D Management Co., Ltd. | Préparation lyophilisée stable |
US20080279930A1 (en) * | 2007-05-07 | 2008-11-13 | Bernd Terhaag | Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof |
US8222282B2 (en) * | 2008-06-09 | 2012-07-17 | Teva Pharmaceuticals Usa, Inc. | Sulfonate salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine |
WO2009152168A2 (en) * | 2008-06-09 | 2009-12-17 | Awd. Pharma Gmbh & Co. Kg | Carboxylic acid salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine |
DE102010030053A1 (de) | 2010-06-14 | 2011-12-15 | Awd.Pharma Gmbh & Co.Kg | Injizierbare Darreichungsform von Flupirtin |
DE102017007385A1 (de) | 2017-08-02 | 2019-02-07 | Christoph Hoock | Maleatfreie feste Arzneimittelformen |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1795858C2 (de) | 1968-07-19 | 1979-01-11 | Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt | Benzylaminopyridine |
DE3133519A1 (de) | 1980-09-13 | 1982-06-09 | Degussa Ag, 6000 Frankfurt | "2-amino-3-carbethoxyamino-6-(p-fluor-benzylamino)-pyridin-maleat" |
US4481205A (en) * | 1980-09-13 | 1984-11-06 | Degussa Aktiengesellschaft | 2-Amino-3-carbethoxyamino-6-(p-fluoro-benzylamino)-pyridine-maleate |
DE3416609A1 (de) * | 1984-05-05 | 1985-11-07 | Degussa Ag, 6000 Frankfurt | 2-amino-3-ethoxycarbonylamino-6-(p-fluor-benzylamino)- pyridin-gluconat und pharmazeutische zubereitungen, die diese substanz enthalten |
JPH0665648B2 (ja) * | 1985-09-25 | 1994-08-24 | 塩野義製薬株式会社 | 白金系抗癌物質の安定な凍結真空乾燥製剤 |
IN172468B (es) * | 1990-07-14 | 1993-08-14 | Asta Medica Ag | |
DE9321574U1 (de) * | 1992-03-11 | 2000-06-29 | Asta Medica Ag | Tabletten, Granulate und Pellets mit hohem Gehalt an Wirkstoffen für hochkonzentrierte, feste Darreichungsformen |
DE4319649A1 (de) | 1993-03-18 | 1994-09-22 | Asta Medica Ag | Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe |
DE4327516A1 (de) | 1993-08-17 | 1995-02-23 | Asta Medica Ag | Primäre und sekundäre neuroprotektive Wirkung bei neurodegenerativen Erkrankungen von Flupirtin |
GB9512854D0 (en) * | 1995-06-23 | 1995-08-23 | Wellcome Found | Novel formulation |
AUPN605795A0 (en) * | 1995-10-19 | 1995-11-09 | F.H. Faulding & Co. Limited | Analgesic pharmaceutical composition |
DE19541405A1 (de) | 1995-11-07 | 1997-05-15 | Asta Medica Ag | Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen, die mit einer Beeinträchtigung des hämatopoetischen Zellsystems einhergehen |
JP2781783B2 (ja) * | 1996-07-30 | 1998-07-30 | 山形日本電気株式会社 | 半導体装置用パッケージ |
US6010719A (en) * | 1997-09-16 | 2000-01-04 | Universiteit Gent | Freeze-dried disintegrating tablets |
DE10048969A1 (de) | 2000-08-23 | 2002-03-14 | Mueller Schwefe Gerhard | Verwendung von Flupirtin zur Tinnitusbehandlung |
US7695736B2 (en) * | 2001-04-03 | 2010-04-13 | Pfizer Inc. | Reconstitutable parenteral composition |
-
2003
- 2003-06-20 DE DE10327674A patent/DE10327674A1/de not_active Withdrawn
-
2004
- 2004-06-16 DK DK08010996.0T patent/DK1987819T3/da active
- 2004-06-16 EP EP08010996A patent/EP1987819B1/de not_active Expired - Lifetime
- 2004-06-16 CN CNA2004800239267A patent/CN1838943A/zh active Pending
- 2004-06-16 UA UAA200600532A patent/UA84155C2/ru unknown
- 2004-06-16 EP EP04739918A patent/EP1638532B1/de not_active Expired - Lifetime
- 2004-06-16 ES ES08010996T patent/ES2388088T3/es not_active Expired - Lifetime
- 2004-06-16 ES ES04739918T patent/ES2322999T3/es not_active Expired - Lifetime
- 2004-06-16 EA EA200600070A patent/EA008145B1/ru not_active IP Right Cessation
- 2004-06-16 PL PL08010996T patent/PL1987819T3/pl unknown
- 2004-06-16 PL PL04739918T patent/PL1638532T3/pl unknown
- 2004-06-16 KR KR1020057024383A patent/KR20060025182A/ko not_active Application Discontinuation
- 2004-06-16 CA CA002528899A patent/CA2528899A1/en not_active Abandoned
- 2004-06-16 TW TW093117391A patent/TWI343261B/zh not_active IP Right Cessation
- 2004-06-16 WO PCT/EP2004/006449 patent/WO2004112754A1/de active Application Filing
- 2004-06-16 US US10/560,420 patent/US20060252804A1/en not_active Abandoned
- 2004-06-16 AT AT08010996T patent/ATE553085T1/de active
- 2004-06-16 RS YUP-2005/0941A patent/RS20050941A/sr unknown
- 2004-06-16 JP JP2006515943A patent/JP4617303B2/ja not_active Expired - Fee Related
- 2004-06-16 PT PT08010996T patent/PT1987819E/pt unknown
- 2004-06-16 AT AT04739918T patent/ATE423549T1/de not_active IP Right Cessation
- 2004-06-16 DE DE502004009045T patent/DE502004009045D1/de not_active Expired - Lifetime
- 2004-06-18 AR ARP040102141A patent/AR044831A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
CN1838943A (zh) | 2006-09-27 |
ES2322999T3 (es) | 2009-07-03 |
PT1987819E (pt) | 2012-07-06 |
EA200600070A1 (ru) | 2006-06-30 |
ATE553085T1 (de) | 2012-04-15 |
DE502004009045D1 (de) | 2009-04-09 |
PL1987819T3 (pl) | 2012-09-28 |
PL1638532T3 (pl) | 2009-07-31 |
DK1987819T3 (da) | 2012-07-16 |
EA008145B1 (ru) | 2007-04-27 |
EP1987819A1 (de) | 2008-11-05 |
TWI343261B (en) | 2011-06-11 |
EP1638532A1 (de) | 2006-03-29 |
ATE423549T1 (de) | 2009-03-15 |
EP1638532B1 (de) | 2009-02-25 |
ES2388088T3 (es) | 2012-10-08 |
DE10327674A1 (de) | 2005-01-05 |
KR20060025182A (ko) | 2006-03-20 |
EP1987819B1 (de) | 2012-04-11 |
UA84155C2 (ru) | 2008-09-25 |
WO2004112754A1 (de) | 2004-12-29 |
JP2007506660A (ja) | 2007-03-22 |
JP4617303B2 (ja) | 2011-01-26 |
TW200509984A (en) | 2005-03-16 |
US20060252804A1 (en) | 2006-11-09 |
RS20050941A (en) | 2007-09-21 |
CA2528899A1 (en) | 2004-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6160321A2 (es) | Uso de 2-6-(3-amino-piperidin-1-il)-3-metil-2,4-dioxo-3,4-dihidro-2h-pirimidin-1-ilmetil-4-fluoro-benzonitrilo | |
BRPI0514474A (pt) | multiparticulados | |
RS51569B (en) | COMPOSITIONS CONTAINING CRYSTAL TRANS - (+/-) - DELTA-9-TETRAHYDROCANABINOL | |
EA201170527A1 (ru) | Фармацевтические композиции, включающие соединения бороновой кислоты | |
ECSP066346A (es) | Forma de administración a prueba de abuso | |
ECSP066345A (es) | Forma de administración a prueba de abuso | |
ECSP088240A (es) | Composición de trazodona para administración una vez por día | |
ECSP003847A (es) | Composiciones farmaceuticas que proporcionan concentraciones potenciadas de farmaco | |
TW200716628A (en) | Novel compounds | |
CL2016000008A1 (es) | Tratamiento de lesiones inflamatorias de rosacea con ivermectina. | |
CL2007001752A1 (es) | Compuesto 4-[5(2-amino-etansulfonil)-isoquinolin-7-il]-fenolo una sal farmaceuticamente aceptable o un hidrato o la sal del mismo;composicion farmaceutica que comprende a dicho compuesto,composicion farmaceutica liofilizada;y uso del compuesto como antineiplasico y/o antiviral. | |
NI200800176A (es) | Uso de derivados de sulfamidas heterocíclicas benzo-fusionadas para el tratamiento de la depresión | |
AR059097A1 (es) | Tratamiento a largo plazo de la infeccion por vih | |
PE20120791A1 (es) | Composiciones y metodos para terapia prolongada con aminopiridinas | |
AR035293A1 (es) | Composicion oftalmica. | |
AR077125A1 (es) | Combinaciones farmaceuticas utiles para tratar el vhc | |
BRPI0311189B8 (pt) | composições farmacêuticas contendo polimorfo a de flibanserin, bem como seu uso | |
UY29069A1 (es) | Uso de compuestos tpo miméticos y composiciones farmacéuticas para el tratamiento de la anemia | |
AR044831A1 (es) | Forma de administracion inyectable de la flupirtina | |
PE20090625A1 (es) | Composicion farmaceutica que contiene buprenorfina y nalmefeno | |
UA93365C2 (ru) | Инъекционная форма диклофенака и его фармацевтически приемлемых солей (варианты) и способ его приготовления (варианты) | |
AR062784A1 (es) | Tratmiento de los vertigos con acetil -l- leucina | |
AR061352A1 (es) | El uso de timosina alfa 1 para preparar un medicamento destinado al tratamiento del melanoma maligno de estadio iv | |
CR10210A (es) | Derivados de benzoisoindol para el tratamiento del dolor | |
PE20130782A1 (es) | Composiciones farmaceuticas que consisten de paracetamol y el proceso para la preparacion del mismo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |